Back to Search Start Over

Health Technology Assessment of Vaccines in Italy: History and Review of Applications.

Authors :
Boccalini, Sara
Ragusa, Rosalia
Panatto, Donatella
Calabrò, Giovanna Elisa
Cortesi, Paolo Angelo
Giorgianni, Gabriele
Favaretti, Carlo
Bonanni, Paolo
Ricciardi, Walter
de Waure, Chiara
Source :
Vaccines; Oct2024, Vol. 12 Issue 10, p1090, 14p
Publication Year :
2024

Abstract

Background/Objectives. Many vaccines have been developed in recent decades, and many more will be available in the future. When new safe and effective vaccines are available, decision-makers must extensively assess them before including them in the national immunization plan and issuing recommendations. The Health Technology Assessment (HTA) could be an objective, transparent, and comprehensive approach to guiding the decision-making process for the use of vaccines. Objectives and Methods. The aim of this study was to review the indications for HTA use contained in Italian institutional documents on vaccination, namely the National Immunization Plans (NIPs) and available full Italian HTA reports on vaccines, assessing their availability at the time of national recommendations' introductions. Results. HTA has been recognised as an eligible approach to deciding upon the introduction of vaccines through the NIPs of 2012–2014 and 2017–2019, and the last NIP, of 2023–2025, highlights the lack of funding dedicated to the production of independent HTA reports that can be used for issuing recommendations. In 2007–2023, twenty full HTA reports on vaccines were published in Italy: eight reports on influenza vaccines, five on Human Papilloma Virus (HPV), three each on meningococcal and pneumococcal vaccines, and one on rotavirus vaccine. HTA was applied with different purposes, namely the evaluation of new vaccines or their re-assessment, but it was not always timely with respect to both the marketing authorisation and the issuing of national recommendations for use. Conclusions. As HTA can be considered the best tool to disentangle the overall value of vaccines, it would be desirable for it to be used more and more to provide the evidence for efficient resource use. This calls for action to improve the transfer of HTA results to decision-makers, to try to fill the gap between research and decision and foster evidence-based recommendations. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
2076393X
Volume :
12
Issue :
10
Database :
Complementary Index
Journal :
Vaccines
Publication Type :
Academic Journal
Accession number :
180529709
Full Text :
https://doi.org/10.3390/vaccines12101090